Skip to content

Validation of the Utility of an Intelligent Visual Acuity Diagnostic System for Children

Validation of the Utility of an Intelligent Visual Acuity Diagnostic System for Children: Using a Human-in-the-loop Artificial Intelligence Paradigm

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03766737
Enrollment
50
Registered
2018-12-06
Start date
2018-05-20
Completion date
2018-07-20
Last updated
2018-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Artificial Intelligence, Ophthalmopathy

Keywords

Vision Disorders

Brief summary

Visual development during early childhood is a vital process. Examining the visual acuity of children is essential for the early detection of visual abnormality, but performing such an assessment in children is challenging. Here, the investigators developed a human-in-the-loop artificial intelligence (AI) paradigm that combines traditional vision examination and AI with integrated software and hardware, thus making the vision examination easy to perform. The investigator also establish a entity intelligent visual acuity diagnostic system based on the paradigm, and conduct clinical trial to validate if the diagnostic system can offsetting the shortcomings of human doctors.

Interventions

DEVICEAn intelligent visual acuity diagnostic system for children

An artificial intelligence to make evaluation and of children's vision.

Sponsors

Sun Yat-sen University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Months to 14 Years
Healthy volunteers
Yes

Inclusion criteria

* Paediatric patients from eye clinic written informed consents provided

Design outcomes

Primary

MeasureTime frame
The proportion of accurate, mistaken and miss detection of the intelligent visual acuity diagnostic system.Up to 5 years

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026